Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Pinto

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studiesP C Wong, E J Crain, B Xin, et al.
Bioorganic & Medicinal Chemistry|March 1, 1995
Metabolism resistant isothiazolone inhibitors of cartilage breakdownS W Wright, J J Petraitis, D G Batt, et al.
Journal of Medicinal Chemistry|October 30, 1992
Synthesis, chemical, and biological properties of vinylogous hydroxamic acids: dual inhibitors of 5-lipoxygenase and IL-1 biosynthesisS W Wright, R R Harris, J S Kerr, et al.
Journal of Medicinal Chemistry|January 3, 1997
Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonistsJ Wityak, T M Sielecki, D J Pinto, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogsD J Pinto, D G Batt, W J Pitts, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic coreJ M Fevig, D J Pinto, Q Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar SodiumW J Pitts, J W Jetter, D J Pinto, et al.
Journal of Medicinal Chemistry|February 15, 2001
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor XaD J Pinto, M J Orwat, S Wang, et al.
Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.
Journal of Medicinal Chemistry|June 20, 1997
Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonistsC B Xue, J Wityak, T M Sielecki, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Thrombosis and Haemostasis : JTH|March 5, 2008
Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studiesP C Wong, E J Crain, B Xin, et al.
Bioorganic & Medicinal Chemistry|March 1, 1995
Metabolism resistant isothiazolone inhibitors of cartilage breakdownS W Wright, J J Petraitis, D G Batt, et al.
Journal of Medicinal Chemistry|October 30, 1992
Synthesis, chemical, and biological properties of vinylogous hydroxamic acids: dual inhibitors of 5-lipoxygenase and IL-1 biosynthesisS W Wright, R R Harris, J S Kerr, et al.
Journal of Medicinal Chemistry|January 3, 1997
Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonistsJ Wityak, T M Sielecki, D J Pinto, et al.
Bioorganic & Medicinal Chemistry Letters|May 7, 1999
Terphenyl cyclooxygenase-2 (COX-2) inhibitors: optimization of the central ring and o-biphenyl analogsD J Pinto, D G Batt, W J Pitts, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2001
Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic coreJ M Fevig, D J Pinto, Q Han, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar SodiumW J Pitts, J W Jetter, D J Pinto, et al.
Journal of Medicinal Chemistry|February 15, 2001
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor XaD J Pinto, M J Orwat, S Wang, et al.
Journal of Medicinal Chemistry|April 10, 1999
Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of actionR E Olson, T M Sielecki, J Wityak, et al.
Journal of Medicinal Chemistry|June 20, 1997
Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonistsC B Xue, J Wityak, T M Sielecki, et al.
Pageof 3